Eledon Pharmaceuticals (ELDN) EPS (Basic) Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -13.31% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -100.00% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 61.11% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3,856.63% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -7.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,207.14% |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - | -312.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -312.50% |
| Dec 31, 2025 | 75.96% |
| Sep 30, 2025 | -120.00% |
| Jun 30, 2025 | 87.74% |
| Mar 31, 2025 | 99.78% |
| Dec 31, 2024 | -1,680.00% |
| Sep 30, 2024 | 418.18% |
| Jun 30, 2024 | 61.31% |
| Mar 31, 2024 | -4,716.00% |
| Dec 31, 2023 | 101.22% |
| Sep 30, 2023 | 54.79% |
| Jun 30, 2023 | -321.54% |
| Mar 31, 2023 | -8.70% |
| Dec 31, 2022 | -581.67% |
| Sep 30, 2022 | -10.61% |
| Jun 30, 2022 | -30.00% |
| Mar 31, 2022 | -21.05% |
| Dec 31, 2021 | -155.05% |
| Sep 30, 2021 | 88.02% |
| Jun 30, 2021 | 81.75% |
| Mar 31, 2021 | 93.31% |
| Dec 31, 2020 | 119.19% |
| Sep 30, 2020 | -37.41% |
| Jun 30, 2020 | -682.86% |
| Mar 31, 2020 | -1,538.46% |
| Dec 31, 2019 | -1,059.18% |
| Sep 30, 2019 | -983.78% |
| Jun 30, 2019 | -2.94% |
| Mar 31, 2019 | -44.44% |
| Dec 31, 2018 | -880.00% |
| Sep 30, 2018 | 13.95% |
| Jun 30, 2018 | 74.24% |
| Mar 31, 2018 | 38.98% |
| Dec 31, 2017 | 70.59% |
| Sep 30, 2017 | 90.11% |
| Jun 30, 2017 | 41.33% |
| Mar 31, 2017 | -15.69% |
| Dec 31, 2016 | 65.31% |
| Sep 30, 2016 | -720.75% |
| Jun 30, 2016 | -462.50% |
| Mar 31, 2016 | 13.56% |
| Dec 31, 2015 | -75.00% |
| Sep 30, 2015 | 80.44% |
| Jun 30, 2015 | 96.58% |
| Mar 31, 2015 | 93.97% |
| Dec 31, 2014 | 97.51% |
| Sep 30, 2014 | 60.26% |